Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
François‐Clément Bidard, Anne‐Claire Hardy‐Bessard, Florence Dalenc, Florence Dalenc, Jean‐Yves Pierga, Jean-Yves Pierga, Thibault de la Motte Rouge, Coraline Dubot, Jean‐Sébastien Frenel, Jean Marc Ferrero, Sylvain Ladoire, Sylvain Ladoire, Marie‐Ange Mouret‐Reynier, Alain Lortholary, Alain Lortholary, Camille Chakiba, Laëtitia Stefani, Jérôme Edouard Plaza, Florian Clatot, Luís Teixeira, Luis Teixeira, Véronique D'Hondt, Olfa Derbel, Claire Garnier-Tixidré, Jean-Luc Canon, Barbara Pistilli, Fabrice André, Laurent Arnould, Anne Pradines, Ivan Bièche, Céline Callens, Jérôme Lemonnier, Frédérique Berger, Suzette Delaloge, François‐Clément Bidard, Barbara Pistilli, Florence Dalenc, Barbara PISTILLI, Florence DALENC, Thomas BACHELOT, Coraline Dubot, Jean‐Sébastien Frenel, Jean-Marc Ferrero, Sylvain Ladoire, Jean-Marc FERRERO, Marie‐Ange Mouret‐Reynier, Anne‐Claire Hardy‐Bessard, Alain Lortholary, Anne-Claire HARDY-BESSARD, Camille Chakiba, Laëtitia Stefani, P Soulié, Jean-Philippe Jacquin, Jérôme Edouard Plaza, Florian Clatot, Luís Teixeira, Florian CLATOT, Luis TEIXEIRA, Olfa Derbel, Claire Garnier Tixidre, Catherine Delbaldo, Lionel MOREAU, Caroline Cheneau, Jean-François Paitel, Chantal BERNARD-MARTY, Dominique Spaëth, Dominique Genet, Isabelle MOULLET, Nathalie BONICHON-LAMICHHANE, Laura DEIANA, Charlotte GREILSAMER, Laurence Venat‐Bouvet, Valérie Delecroix, Adrien MELIS, Hubert Orfeuvre, Suzanne Nguyen, Éric Legouffe, Alain Zannetti, Romuald Le Scodan, Nadine Dohollou, Philippe DALIVOUST, Olivier Arsène, Nathalie MARQUES, Thierry Petit, Delphine MOLLON, Jérôme Dauba, Nathalie Bonnin, François MORVAN, Miriam Gardner, Adina MARTI, Charles-Briac Levaché, Emma Lachaier, Mihaela ACHILLE, Christophe VALMAR, Ryan Bouaita, Jacques Médioni, Cyril Foa, Chantal BERNARD-MARTY, Francesco Del Piano, Michel GOZY